Panic Disorder
Also known as: Disorder, Syndrome, Diseases, Condition
Methodology & AI Transparency ⓘ
Panic Disorder Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: What is panic disorder? Panic disorder is a type of anxiety disorder .
- 2 Real-world patient consensus: Mapped to Anxiety, OCD & Trauma Disorders under ICD-10-CM F41.0 for Panic Disorder clinical workups.
- 3 Typical cash cost range: Primary evaluation for Panic Disorder incorporates functional impairment review [Panic Disorder F41.0] and symptom diary review.
- 4 Top reported side effects / signs: Key Anxiety & PTSD biomarkers for Panic Disorder (F41.0): Resting Heart Rate in Panic Disorder (F41.0: Variability (HRV)) & TSH & Ferritin in Panic Disorder (F41.0: Rule-Out) (TSH 0.8–2.5 mIU/L; Ferritin > 50 ng/mL (F41.0)).
Ask our AI Specialists anything about Panic Disorder
What Is Panic Disorder?
What is panic disorder? Panic disorder is a type of anxiety disorder . It causes repeated panic attacks, which are sudden periods of intense fear, discomfort, or a sense of losing control. These attacks happen even though there is no real danger. They often cause physical symptoms. For example, you may have a rapid or pounding heartbeat and feel like you are having a heart attack . If you have panic attacks, it doesn't mean you will develop a panic disorder. Many people only have one or two panic attacks in their lifetime and get better without treatment. But some of the people who have panic attacks do develop panic disorder. They have repeated panic attacks.
Pathophysiology, Underlying Causes & Clinical Presentation
Biological expression of Panic Disorder (F41.0, Anxiety & PTSD) reflects sympathetic locus coeruleus in Panic Disorder (F41.0: noradrenergic surges). Cross-referenced with NIH MeSH (Panic Disorder), longitudinal control is benchmarked via Resting Heart Rate in Panic Disorder (F41.0: Variability (HRV)).
Common Symptoms & Clinical Signs
- • Genetics - panic disorder sometimes runs in families. But no one knows for sure why some family members have it while others don't
- • Brain biology and chemistry
- • Presentation of Panic Disorder (F41.0): chronic neck, jaw, in Panic Disorder (F41.0: and shoulder muscle)
- • Secondary Panic Disorder clinical sign: avoidance of triggers, in Panic Disorder (F41.0: intrusive trauma memories,)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Panic Disorder Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | F41.0 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Anxiety, OCD & Trauma Disorders | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Resting Heart Rate in Panic Disorder (F41.0: Variability (HRV)) | Stable upward personal trend (F41.0) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: TSH & Ferritin in Panic Disorder (F41.0: Rule-Out) | TSH 0.8–2.5 mIU/L; Ferritin > 50 ng/mL (F41.0) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: GAD-7 Anxiety Severity in Panic Disorder (F41.0: Score) | < 4 (minimal anxiety) (F41.0) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Panic Disorder
Treatment selection for Panic Disorder depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Panic Disorder)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| What the Latest Evidence Really Says About Comparative real-world benefits and safety of Benzodiazepines in the Treatment of BZDs are overall efficacious for the treatment of GAD and have a favorable safety profile. Psychotherapy and psychosomatics • 2025-01-15 • Meta-Analysis | Multi-cohort | 92/100 | PMID 40544830 ↗ |
| What the Latest Evidence Really Says About Drug treatment for panic disorder with or without agoraphobia: systematic review The findings suggest that SSRIs provide high rates of full symptom relief with low risk of side effects for the treatment of panic disorder. BMJ (Clinical research ed.) • 2022-01-19 • Meta-Analysis | Multi-cohort | 92/100 | PMID 35045991 ↗ |
| Can This Approach Help? Inside the Latest Research on Benefits and safety of fixed-dose clindamycin phosphate 1.2%/adapalene This study provides support for acne treatment with CAB in ethnically diverse populations. The Journal of dermatological treatment • 2025-12-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 40122140 ↗ |
| Can This Approach Help? Inside the Latest Research on Consistent response to guselkumab treatment between Hispanic and non-Hispanic Guselkumab safety and real-world benefits were consistent between Hispanic and non-Hispanic populations. The Journal of dermatological treatment • 2021-08-15 • Phase III Randomized Trial | N = 117 | 88/100 | PMID 31613178 ↗ |
| Can This Approach Help? Inside the Latest Research on Benefits and safety of bictegravir/emtricitabine/tenofovir alafenamide in Black These results demonstrate the durability and long-term safety of B/F/TAF in Black and Hispanic/Latine people with HIV. HIV medicine • 2025-06-15 • Phase III Randomized Trial | Multi-cohort | 82/100 | PMID 40116337 ↗ |
Panic Disorder Patient Community & “People Like Me” Threads
Filter Panic Disorder community threads and patient logs by age, biological sex, dosage, and treatment duration.